Venous Sclerosants: Cardiovascular Adverse Effects and Misuse
    GCM team May 7, 2026 No Comments

    Key Overview • Study Basis: In France, the marketed venous sclerosants are Aetoxisclerol (the

    READ MORE
    Does Eliminating Reflux Always Require Ablating the Great Saphenous Vein?
    GCM team May 7, 2026 No Comments

    Key Points • Study basis: In 2001, Paolo Zamboni and colleagues published a study

    READ MORE
    What Makes CHIVA Difficult Is Not the Procedure Alone
    GCM team April 28, 2026 No Comments

    Key Points Study basis: In 2024, Stefano Ricci published CHIVA for dummies in Phlebology,

    READ MORE
    When the Main Deep Venous Pathway Is Closed, the Great Saphenous Vein May Become the Last Compensatory Channel
    GCM team April 27, 2026 No Comments

    Key Points Study basis: A 2026 case report published in Case Reports in Cardiology

    READ MORE
    What Happens to Ulcer Outcomes in PTS Patients When the Great Saphenous Vein Is Missing?
    GCM team April 17, 2026 No Comments

    Key Points •Study basis: A 2024 retrospective comparative study published in the Journal of

    READ MORE
    CHIVA Is Entering a More Organized Phase of Global Expansion
    GCM team April 15, 2026 No Comments

    Key Points Program basis: APCA describes the Global CHIVA Program as a global education,

    READ MORE
    A 2025 Review Offers a Longer-Term Perspective: The Value of Preserving the Great Saphenous Vein in CHIVA Goes Beyond Being Minimally Invasive
    GCM team April 10, 2026 No Comments

    Key Points Study basis: In 2025, Hidayet Tarik Kiziltan, Stefano Ermini, and Claude Franceschi

    READ MORE
    From “Removal” to “Correction”: A 2023 Review Re-emphasizes the True Positioning of CHIVA
    GCM team April 9, 2026 No Comments

    Key Points • Article background: In 2023, Roberto Delfrate published a review in the

    READ MORE
    A Meta-analysis of 14 High-Quality Studies Further Confirms the Minimally Invasive and Safety Advantages of CHIVA
    GCM team April 7, 2026 No Comments

    Key Points •Study basis: A 2023 meta-analysis published in Medicine (Baltimore) included 14 high-quality

    READ MORE
    Global CHIVA Program Tier 1 pilot soft launch announcement featuring program modules and enrollment information.
    Global CHIVA Program Enters Tier 1 Pilot Phase, Marking a New Milestone in Standardized Venous Education
    Admin December 11, 2025 No Comments

    December 8, 2025 (United States) The Global CHIVA Program has officially entered the soft-launch

    READ MORE
    Page1 Page2 Page3 Page4
    Recent Post

    DR. SMILE MEDICAL GROUP Granted HMO NPI – Paving the Way for Medical Network Expansion

    June 9, 2025

    Global CHIVA Management (GCM) Registered as Official Trade Name in New York State

    June 9, 2025

    Dr. Qiang Zhang Meets Vascular Care Group: Accelerating CHIVA Adoption in North America and Building Global Collaboration

    June 26, 2025
    Gallery

    Stay Connected with GCM

    Subscribe to our newsletter for updates on CHIVA insights, training, and global developments.

    CALL US

    COMING SOON

    EMAIL US

    contact@globalchiva.com

    ADDRESS

    36 East 36th Street New York, NY 10016

    © 2025 DR.SMILE MEDICAL GROUP, INC. All rights reserved..Global CHIVA Management iS a DBA Of DR.SMILE MEDICAL GROUP, INC